These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9688372)

  • 21. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation.
    Artini PG; Monti M; Matteucci C; Valentino V; Cristello F; Genazzani AR
    Gynecol Endocrinol; 2006 Aug; 22(8):465-70. PubMed ID: 17012110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of octreotide-LAR in dieting women with abdominal obesity and polycystic ovary syndrome.
    Gambineri A; Patton L; De Iasio R; Cantelli B; Cognini GE; Filicori M; Barreca A; Diamanti-Kandarakis E; Pagotto U; Pasquali R
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3854-62. PubMed ID: 15827099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome.
    Tessaro I; Modina SC; Franciosi F; Sivelli G; Terzaghi L; Lodde V; Luciano AM
    J Ovarian Res; 2015 Oct; 8():64. PubMed ID: 26437930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination.
    Palomba S; Falbo A; Orio F; Manguso F; Russo T; Tolino A; Annamaria C; Dale B; Zullo F
    Hum Reprod; 2005 Oct; 20(10):2879-86. PubMed ID: 15958399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Octreotide effect on ovarian morphology in insulin-resistant PCOS patients following six-month decapeptyl treatment.
    Goni MH; Markussis V; Tolis G
    Am J Reprod Immunol; 1994; 31(2-3):104-11. PubMed ID: 8049019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian stimulation with low-dose pure follicle-stimulating hormone in polycystic ovarian syndrome anovulatory patients: effect of long-term pretreatment with gonadotrophin-releasing hormone analogue.
    Vegetti W; Testa G; Ragni G; Parazzini F; Crosignani PG
    Gynecol Obstet Invest; 1998; 45(3):186-9. PubMed ID: 9565144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A; Sauter L; Edimiris P; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
    Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone.
    Kolibianakis EM; Papanikolaou EG; Tournaye H; Camus M; Van Steirteghem AC; Devroey P
    Fertil Steril; 2007 Nov; 88(5):1382-8. PubMed ID: 17445806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R
    Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.
    Fauser BC; Alper MM; Ledger W; Schoolcraft WB; Zandvliet A; Mannaerts BM;
    Reprod Biomed Online; 2010 Nov; 21(5):593-601. PubMed ID: 20843746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations.
    Zaidi J; Jacobs H; Campbell S; Tan SL
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):188-96. PubMed ID: 9793191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of gonadotrophin-releasing hormone agonist on follicular development in patients with polycystic ovary syndrome in an in-vitro fertilization and embryo transfer programme.
    Gersak K; Meden-Vrtovec H; Tomazevic T
    Hum Reprod; 1994 Sep; 9(9):1596-9. PubMed ID: 7836506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovulation induction with low doses of "pure" follicle stimulating hormone using a fixed protocol in patients with polycystic ovarian disease.
    Bregieiro LO; de Moura MD; Ferriani RA; Bailão LA; de Sá MF
    Int J Fertil Menopausal Stud; 1993; 38(3):152-9. PubMed ID: 8348163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome.
    Rouzi AA; Ardawi MS
    Fertil Steril; 2006 Feb; 85(2):428-35. PubMed ID: 16595222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of metformin on gonadotropin-induced ovulation in patients with polycystic ovary syndrome].
    Zhao JZ; Ye BL; Lin JJ; Lin WQ; Chi HH
    Zhonghua Fu Chan Ke Za Zhi; 2003 Sep; 38(9):545-8. PubMed ID: 14680609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.
    Palomba S; Falbo A; Di Cello A; Cappiello F; Tolino A; Zullo F
    Fertil Steril; 2011 Nov; 96(5):1128-33. PubMed ID: 21917254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of a somatostatin analogue in lowering luteinizing hormone and insulin-stimulated secretion in hyperinsulinemic women with polycystic ovary disease.
    Fulghesu AM; Lanzone A; Andreani CL; Pierro E; Caruso A; Mancuso S
    Fertil Steril; 1995 Oct; 64(4):703-8. PubMed ID: 7672138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of intermediate-dose purified urinary follicle-stimulating hormone with and without human chorionic gonadotropin for ovulation induction in polycystic ovarian disease.
    Claman P; Seibel MM; McArdle C; Berger MJ; Taymor ML
    Fertil Steril; 1986 Sep; 46(3):518-21. PubMed ID: 3091412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.